Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Compass Therapeutics, Inc. (CMPX) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-66.49M |
|
-- |
|
-- |
|
$72.84M |
|
$-72.84M |
|
$6.35M |
|
$-66.49M |
|
$-66.49M |
|
$-66.49M |
|
$-66.49M |
|
$-66.49M |
|
$-66.49M |
|
$-72.84M |
|
$-73.04M |
|
157.69M |
|
157.69M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$209.82M |
|
$0.10M |
|
$9.77M |
|
$219.59M |
|
$13.97M |
|
-- |
|
$8.83M |
|
$22.80M |
|
$196.79M |
|
$196.79M |
|
$196.79M |
|
178.32M |
|
| Cash Flow Statement Financials | |
$-49.14M |
|
$-93.31M |
|
$129.61M |
|
$44.05M |
|
$31.21M |
|
$-12.84M |
|
$8.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.02 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.79% |
|
-33.79% |
|
-30.28% |
|
-33.79% |
|
$1.10 |
|
$-0.31 |
|
$-0.31 |
|